Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

M. Matsuo, H. Sakurai, Y. Ueno, O. Ohtani, I. Saiki

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)242
Number of pages1
JournalCancer Science
Volume97
Issue number3
DOIs
StatePublished - 2006/03

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this